Dulaglutide Webinar - The Long-awaited New Agent to treat Type 2 diabetes

Fri, 29 Aug 2025 12:05:47 +0000

Dr Paul Ryan
Dr Ryan Paul is an Executive Member of the New Zealand Society for the Study of Diabetes (NZSSD) and recently led the development of the NZSSD guidance on the management of type 2 diabetes in New Zealand. Dr Paul is heavily involved in teaching primary care clinicians, diabetes nurse prescribers and endocrinology trainees.
THE TOPIC WILL INCLUDE:
• When + how to use dulaglutide for type 2 diabetes
• Advice on whether to choose funded dulaglutide or empagliflozin and when to switch between the two
• When to advise to self-fund dulaglutide
• The potential for dulaglutide to get patients o insulin
• The role of dulaglutide in primary + secondary prevention of CVD